ReviewFrontiers in medicine2026
Vietnam Association of Gastroenterology (VNAGE) guideline on the management of gastroesophageal reflux disease.
Review in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
28 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Gastroesophageal reflux disease (GERD) is common and heterogeneous, with growing recognition of nonerosive reflux disease (NERD) and extraesophageal manifestations in Asia. The variations in diagnostic resources and clinical practice necessitate context-specific, evidence-based guidance. Thus, we developed a guideline that aims to standardize the diagnosis and management of GERD in Vietnam. Methods: A multidisciplinary panel conducted a structured literature search and developed consensus statements using a modified Delphi process. Evidence quality and recommendation strength were evaluated using the GRADE framework. Results: Twenty recommendations address the diagnostic and therapeutic strategies. Upper endoscopy and ambulatory reflux monitoring are recommended for selected patients, whereas high-resolution manometry is advised for those with refractory symptoms and for preintervention evaluation. Empiric proton pump inhibitor (PPI) testing alone is insufficient for diagnosis. Lifestyle modification and optimized PPI therapy remain the first-line treatments. Standard-duration PPI therapy is recommended for patients with NERD and erosive esophagitis, with optimization required before defining refractory GERD. Potassium-competitive acid blockers may be considered as alternatives. Endoscopic and surgical interventions are reserved for patients with objective reflux and persistent symptoms despite undergoing optimized medical therapy. Conclusion: The developed guideline provides evidence-based, context-adapted recommendations to standardize GERD care in Vietnam.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.